HDAC6 and medulloblastoma: To investigate the long-term effect of a simultaneous inhibition of HDAC6, 8 and 10 on pediatric cancer cell lines, we treated five neuroblastoma and two medulloblastoma cell lines, featuring different genetic aberrations, with TH34 for 4 days and allowed remaining cells to regrow colonies in fresh media for another 7 days.